The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Cherington Charles since 2022.
This trader's CIK number is 1448698.
At the time of last reporting, Cherington Charles was the Officer of Ernexa Therapeutics Inc.. (stock ticker symbol ERNA).
Also see all insider trading activities at Ernexa Therapeutics Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | CMRA | 2,933,984 | $1,499,265 | 0 | $0 | 0 | $0 |
2022 | CMRA | 74,907 | $126,923 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | ERNA | 25,009,560 | $2,626,003 | 0 | $0 | 0 | $0 |
2024 | ERNA | 13,252,112 | $0 | 0 | $0 | 0 | $0 |
2022 | ERNA | 261,756 | $858,559 | 0 | $0 | 0 | $0 |
1. Comera Life Sciences Holdings, Inc. (CMRA)
2. Ernexa Therapeutics Inc. (ERNA)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-09-11 | CMRA | Buy | 2,053,789 | .51 | 1,049,486 |
2023-07-31 | CMRA | Buy | 880,195 | .51 | 449,779 |
2022-10-20 | CMRA | Buy | 3,316 | 1.52 | 5,046 |
2022-10-21 | CMRA | Buy | 11,691 | 1.59 | 18,635 |
2022-10-14 | CMRA | Buy | 4,253 | 1.60 | 6,821 |
2022-10-17 | CMRA | Buy | 15,266 | 1.66 | 25,341 |
2022-10-13 | CMRA | Buy | 10,481 | 1.66 | 17,387 |
2022-09-29 | CMRA | Buy | 17,900 | 1.87 | 33,473 |
2022-09-27 | CMRA | Buy | 12,000 | 1.69 | 20,220 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-06-09 | ERNA | Buy | 21,241,163 | .10 | 2,230,322 |
2025-04-02 | ERNA | Buy | 3,768,397 | .10 | 395,681 |
2024-10-29 | ERNA | Buy | 13,252,112 | .00 | 0 |
2022-12-02 | ERNA | Buy | 261,756 | 3.28 | 858,559 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cherington Charles (Officer of Ernexa Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.